Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
29
The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005. Votrient is an oral medication that interferes with angiogenesis, the growth of new blood vessels needed for solid tumors to grow and survive.
28
Although Breast Cancer Awareness Month is coming to an end, smart women know that taking care of their health is important throughout the year. What's more, women age 25 and older now have a tool to help them understand their potential risk for breast cancer. Based on the same science as the PAP test for cervical cell changes, HALO(R) is the only FDA-cleared risk assessment tool for non-hereditary breast cancer.
27
NeoPharm, Inc. today announced that it has submitted a Phase II protocol to the FDA for the study of liposome entrapped docetaxel (LE- DT), a novel, proprietary liposomal delivery system of docetaxel, the active ingredient of Taxotere(R), for locally advanced or metastatic pancreatic cancer patients.
ImmunoCellular Therapeutics, Ltd. (IMUC), a biotechnology company that is focused on the development of novel immune-based cancer therapies, today announced additional data from its Phase I clinical trial evaluating ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme (GBM).
The U.S. Food and Drug Administration today approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL), a slowly progressing cancer of the blood and bone marrow.
26
Does it make sense to offer cancer screenings to older adults? Experts' opinions vary. The Tribune asked several leading organizations to describe their policies for people considered to be low risk, without symptoms of potential illness.
When Ellen Currotto was diagnosed with breast cancer, when part of her breast was removed, when she endured weeks of chemotherapy and lost her hair, when she underwent radiation, all of these months she focused on just one thing: Being done.
It was less than 20 years ago when Dr. Nancy E. Davidson was in the audience to hear geneticist Mary-Claire King announce she had identified the chromosome with a gene responsible for some inherited breast cancer. In the ensuing years, researchers isolated the BRCA1 and BRCA2 genes, invented lab tests to identify those at risk and developed treatments proven to reduce the risk by up to 90 percent.
While the nation is debating how best to reform healthcare, the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) announce a new significant tool to improve the quality of care for patients who suffer from brain tumors.
A team of Canadian cardiologists, in collaboration with oncologists, are playing an important role in the war against breast cancer Dr. Michael McDonald told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
We care about your feedback. Let us know how we can improve your CancerCompass experience.